digoxigenin has been researched along with Breast Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, GZ; Ma, L; Meng, G; Wu, ZS | 1 |
| Huang, D; Ji, Z; Liu, C; Su, J; Wang, H; Zhou, X | 1 |
| Chen, H; Lee, JS; Patel, Y | 1 |
| Dedes, KJ; Geyer, FC; Lacroix-Triki, M; Lambros, MB; Lopez-Garcia, MA; Natrajan, R; Reis-Filho, JS; Savage, K; Vatcheva, R; Wetterskog, D; Wilkerson, P | 1 |
| Chiesa, J; Lobie, PE; Mertani, HC; Perry, JK; Qian, PX; Wan, Y; Wu, ZS; Yang, K; Zhu, T | 1 |
| Bastert, G; Eichler, A; Kaul, S; Zhong, X | 1 |
| Bast, RC; Hoque, A; Lippman, SM; Liu, J; Lu, Z; Luo, RZ; Nishimoto, A; Sahin, AA; Wang, L; Yu, Y; Yuan, J | 1 |
| Antoine, M; Arnould, L; Balaton, A; Baranzelli, MC; Becette, V; Bellocq, JP; Bibeau, F; Couturier, J; Denoux, Y; Ettore, F; Fiche, M; Fridman, V; Gnassia, JP; Jacquemier, J; Lannes, B; MacGrogan, G; Mathieu, MC; Migeon, C; Penault-Llorca, F; Rigaud, C; Roger, P; Sigal-Zafrani, B; Simony-Lafontaine, J; Trassard, M; Treilleux, I; Verriele, V; Vincent-Salomon, A; Voigt, JJ | 1 |
| Bottin, MC; Colosetti, P; Edorh, A; Guillemin, F; Le Faou, A; Merlin, JL; N'Sossani, B; Parache, RM; Rihn, B | 1 |
| Beraki, K; Jebsen, PW; Naess, O; Ormerod, E; Sauer, T | 1 |
| Chiu, SC; Harn, HJ; Ho, LI; Lee, WH; Shen, KL; Yu, CP | 1 |
| Bolkent, S; Kaner, G; Oztürk, M; Unal, H; Yilmazer, S | 1 |
| Arseniev, L; Ganser, A; Kadar, J; Lichtinghagen, R; Petersen, D; Trummer, A | 1 |
1 review(s) available for digoxigenin and Breast Neoplasms
| Article | Year |
|---|---|
[HER2 gene amplification assay: is CISH an alternative to FISH?].
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Chromogenic Compounds; Chromosomes, Human, Pair 17; Digoxigenin; DNA Probes; Female; Genes, erbB-2; Humans; In Situ Hybridization; In Situ Hybridization, Fluorescence; Nucleic Acid Amplification Techniques; Proto-Oncogene Mas; Specimen Handling | 2003 |
12 other study(ies) available for digoxigenin and Breast Neoplasms
| Article | Year |
|---|---|
Prognostic significance of let-7b expression in breast cancer and correlation to its target gene of BSG expression.
Topics: Adult; Aged; Basigin; Biomarkers, Tumor; Breast Diseases; Breast Neoplasms; Digoxigenin; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Middle Aged; Oligonucleotide Probes; Prognosis; Retrospective Studies; Treatment Outcome | 2014 |
Integrating genomics and proteomics data to predict drug effects using binary linear programming.
Topics: Antineoplastic Agents; Benzamides; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Digoxigenin; Female; Gene Expression; Gene Regulatory Networks; Genomics; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Hydroxamic Acids; MCF-7 Cells; Phosphorylation; Programming, Linear; Proteome; Proteomics; Pyridines; Signal Transduction; Staurosporine; Tumor Suppressor Protein p53 | 2014 |
Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization.
Topics: Breast Neoplasms; Digoxigenin; Humans; In Situ Hybridization; MicroRNAs | 2016 |
Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.
Topics: Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Chromogenic Compounds; Chromosomes, Human, Pair 11; Cortactin; Cyclin D1; Digoxigenin; Disease-Free Survival; Female; Gene Amplification; Humans; Immunohistochemistry; In Situ Hybridization; Kaplan-Meier Estimate; London; Mastectomy; Neoplasm Staging; Predictive Value of Tests; Retrospective Studies; Time Factors; Tissue Array Analysis; Treatment Outcome; Up-Regulation | 2010 |
Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.
Topics: Aged; Biomarkers, Tumor; Breast Neoplasms; Digoxigenin; Endometrial Neoplasms; Female; Human Growth Hormone; Humans; Immunohistochemistry; In Situ Hybridization; Kaplan-Meier Estimate; Middle Aged; Oligonucleotides, Antisense; Paraffin Embedding; Placental Lactogen; Prognosis; Prolactin; Receptor, ErbB-2; RNA, Messenger; Survival; Treatment Outcome | 2011 |
Non-radioactive hybridization in microwells using enzyme linked immune sorbent assay for detection of RT-PCR-amplified CK19- and CEA-mRNA.
Topics: Bone Marrow Cells; Breast Neoplasms; Carcinoembryonic Antigen; Digoxigenin; Enzyme-Linked Immunosorbent Assay; Female; Humans; Keratins; Neoplastic Cells, Circulating; Nucleic Acid Hybridization; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity | 1999 |
Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Blotting, Western; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytoplasm; Digoxigenin; Disease Progression; DNA, Complementary; Down-Regulation; Female; Genes, Tumor Suppressor; Humans; Immunohistochemistry; In Situ Hybridization; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; RNA; RNA, Messenger; Sensitivity and Specificity; Transfection | 2003 |
Determination of amplification level of the c-erbB-2 proto-oncogene in human breast carcinomas: a comparative study between non-radioactive and radioactive labelling.
Topics: Base Sequence; Breast Neoplasms; Carcinoma, Ductal, Breast; Colorimetry; Digoxigenin; DNA Primers; DNA, Neoplasm; Evaluation Studies as Topic; Female; Gene Amplification; Genes, erbB-2; Humans; Interferon-gamma; Molecular Probes; Molecular Sequence Data; Phosphorus Radioisotopes; Polymerase Chain Reaction; Proto-Oncogene Mas | 1995 |
In situ hybridization of chromosome 6 on fine-needle aspirates from breast carcinomas: comparison of numerical abnormalities and ER/PgR status and staining pattern.
Topics: Biopsy, Needle; Breast Neoplasms; Cell Nucleus; Chromosome Aberrations; Chromosomes, Human, Pair 6; Coloring Agents; Digoxigenin; DNA Probes; Female; Humans; In Situ Hybridization; Receptors, Estrogen; Receptors, Progesterone | 1997 |
The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling.
Topics: Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cell Division; Cell Survival; Deoxyuracil Nucleotides; Digoxigenin; DNA Fragmentation; DNA Nucleotidylexotransferase; DNA, Neoplasm; Female; Genes, bcl-2; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Neoplasm Invasiveness; Receptors, Estrogen; Receptors, Progesterone; Tumor Suppressor Protein p53 | 1998 |
Detection of c-erbB-2 mRNAs using dig-labelled oligonucleotide probe with in situ hybridisation in human breast carcinoma: comparison with immunohistochemical results.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Papillary; Digoxigenin; Female; Gene Amplification; Gene Expression; Genes, erbB-2; Humans; Immunohistochemistry; In Situ Hybridization; Oligonucleotide Probes; Prognosis; RNA, Messenger; RNA, Neoplasm | 1998 |
Competitive cytokeratin 19 RT-PCR for quantification of breast cancer cells in blood cell suspensions.
Topics: Antibodies; Binding, Competitive; Blood Specimen Collection; Breast Neoplasms; Digoxigenin; DNA Primers; DNA Probes; Enzyme-Linked Immunosorbent Assay; Female; Humans; Keratins; Leukocytes, Mononuclear; Pseudogenes; Reference Standards; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Sensitivity and Specificity | 2000 |